[SAT-219] ATTAINMENT OF NORMAL SERUM K+ RANGE IN CKD PATIENTS WITH MODERATE-TO-SEVERE HYPERKALEMIA ON RAAS INHIBITORS: CLINICAL TRIAL RESULTS WITH PATIROMER FOR ORAL SUSPENSION

M. Epstein, B. Palmer, M. Mayo, D. Garza, Y. Stasiv, C. Du Mond, L. Berman, V. Campese

 

Please enter your mobile phone number. Make sure you add your country code (i.e. +31).
(Message is limited to 160 characters)

Your mobile number: Your message: